Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cusan

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Menopause (New York, N.Y.)|March 4, 2015
Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)David F Archer, Fernand Labrie, Céline Bouchard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 20, 2006
Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in womenFernand Labrie, Alain Bélanger, Patrick Bélanger, et al.
Scientific Reports|April 6, 2017
Loss of p27<sup>kip1</sup> increases genomic instability and induces radio-resistance in luminal breast cancer cellsStefania Berton, Martina Cusan, Ilenia Segatto, et al.
Cancer Letters|November 1, 2024
Clinical challenges in prostate cancer management: Metastatic bone-tropism and the role of circulating tumor cellsGayathri K Guruvayurappan, Tina Frankenbach-Désor, Markus Laubach, et al.
Nature Cell Biology|October 21, 2024
Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forcesPatrizia Romani, Giada Benedetti, Martina Cusan, et al.
The Journal of Organic Chemistry|July 10, 2001
Novel versatile fullerene synthonsK Kordatos, T Da Ros, S Bosi, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Menopause (New York, N.Y.)|May 14, 2015
Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal womenDavid J Portman, Fernand Labrie, David F Archer, et al.
Oncotarget|September 1, 2016
p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanismsIlenia Pellizzari, Linda Fabris, Stefania Berton, et al.
Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Menopause (New York, N.Y.)|March 4, 2015
Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)David F Archer, Fernand Labrie, Céline Bouchard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 20, 2006
Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in womenFernand Labrie, Alain Bélanger, Patrick Bélanger, et al.
Scientific Reports|April 6, 2017
Loss of p27<sup>kip1</sup> increases genomic instability and induces radio-resistance in luminal breast cancer cellsStefania Berton, Martina Cusan, Ilenia Segatto, et al.
Cancer Letters|November 1, 2024
Clinical challenges in prostate cancer management: Metastatic bone-tropism and the role of circulating tumor cellsGayathri K Guruvayurappan, Tina Frankenbach-Désor, Markus Laubach, et al.
Nature Cell Biology|October 21, 2024
Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forcesPatrizia Romani, Giada Benedetti, Martina Cusan, et al.
The Journal of Organic Chemistry|July 10, 2001
Novel versatile fullerene synthonsK Kordatos, T Da Ros, S Bosi, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Menopause (New York, N.Y.)|May 14, 2015
Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal womenDavid J Portman, Fernand Labrie, David F Archer, et al.
Oncotarget|September 1, 2016
p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanismsIlenia Pellizzari, Linda Fabris, Stefania Berton, et al.
Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Pageof 14